Why Procter & Gamble’s Quieter Dividend Outpaces Johnson & Johnson’s Growth Story
Both Johnson and Johnson and Procter & Gamble just refreshed decades-long dividend streaks, but one company has a corporate event on the horizon that has derailed other legendary payout records before.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) and Procter & Gamble (NYSE:PG) both recently refreshed their long dividend records. J&J posted Q1 2026 revenue of $24.06 billion and P&G closed fiscal 2026 with core EPS of $6.89. One is heading into a spinoff while the other stays intact, and that structural difference defines the comparison.
How Each Payout Actually Landed This Cycle
J&J lifted its quarterly dividend to $1.34 per share, with an ex-date of August 25, 2026, and a September 8 payment. The trailing 12-month total is $5.28, with the forward annualized total at $5.36. Growth is doing the heavy lifting: Darzalex at $4.21 billion (+22.5%) and Tremfya at $2.05 billion (+68.3%) more than offset Stelara’s revenue erosion of 55.7%.
P&G paid $1.0885 per share on August 17, 2026, with forward annualized of $4.354. Fiscal 2026 organic sales grew more than 1%, and management returned over $15 billion to shareowners, including more than $10 billion in dividends. Growth, not coverage, is the concern.
| Metric | JNJ | PG |
| Latest quarterly dividend | $1.34 | $1.0885 |
| Forward annualized | $5.36 | $4.354 |
| 1-year price change | +53.4% | −4.9% |
Where the Two Streaks Really Diverge
J&J is heading into a corporate event that has broken other long streaks. CFO Joe Wolk said the company is “on track for a mid-2027 separation” of DePuy Synthes, with more updates expected later in 2026. The precedent cuts both ways. The Kenvue separation in 2023 came and went without a rebase, and quarterly dividends rose from $1.13 in 2022 to $1.34 today. 3M’s payout did not survive its Solventum spinoff intact.
P&G has no such event. New CEO Shailesh Jejurikar said, “we continue to believe the strategy is right,” backing it with $2.8 billion of pre-tax productivity savings. Fiscal 2027 guidance still calls for $10 billion in dividends and roughly $5 billion in buybacks, absorbing a $1 billion after-tax commodity headwind.
A Price Paradox Investors Keep Missing
The stock with the quieter payout has been the worse performer. PG is up just 1.3% year to date, while JNJ has climbed 28.5% YTD. Pipeline strength, not payout policy, drove that gap. CEO Duato reminded investors that the company has 28 platforms each generating more than $1 billion in annual revenue.
Verdict
For a retirement income investor wondering which payout is less likely to be disturbed by a corporate action, the answer is P&G. No separation is planned, coverage is generous, and productivity is funding the raise. (If you want a broader shortlist of 50-year raisers screened by valuation, we put 10 of them in a free Dividend Kings report.)
J&J’s payout looks equally covered, with FY2025 operating cash flow of $24,530 million against dividends paid of $12,381 million, but the DePuy Synthes carve-out is exactly the type of event that has tested streaks before. One specific thing to watch is J&J’s Enterprise Business Review on December 8. If management reaffirms the dividend framework alongside the separation terms, the dividend streak will likely continue uninterrupted.
Contact [email protected] for any questions or corrections.







